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Abstract: Disinfection is crucial to control and prevent microbial pathogens on surfaces. Nonetheless,
disinfectants misuse in routine disinfection has increased the concern on their impact on bacterial resistance
and cross-resistance. This work aims to develop a formulation for surface disinfection based on the
combination of a natural product, cinnamaldehyde, and a widely used biocide, cetyltrimethylammonium
bromide. The wiping method was based on the Wiperator test (ASTM E2967−15) and the efficacy
evaluation of surface disinfection wipes test (EN 16615:2015). After formulation optimization,
the wiping of a contaminated surface with 6.24 log10 colony-forming units (CFU) of Escherichia coli or
7.10 log10 CFU of Staphylococcus aureus led to a reduction of 4.35 log10 CFU and 4.27 log10 CFU when
the wipe was impregnated with the formulation in comparison with 2.45 log10 CFU and 1.50 log10 CFU
as a result of mechanical action only for E. coli and S. aureus, respectively. Furthermore, the formulation
prevented the transfer of bacteria to clean surfaces. The work presented highlights the potential of a
combinatorial approach of a classic biocide with a phytochemical for the development of disinfectant
formulations, with the advantage of reducing the concentration of synthetic biocides, which reduces
the potentially negative environmental and public health impacts from their routine use.
Keywords: bacteria; cinnamaldehyde; cetyltrimethylammonium bromide; formulation; surface
disinfection
1. Introduction
Surface disinfection, when effective, is a part of a multibarrier strategy in fighting microbial
contamination, such as preventing food spoilage and patient infection in healthcare settings. In fact,
recently, the risk of foodborne transmission has increased due to consumer habits that include
the consumption of raw vegetables and undercooking to retain the natural taste and to preserve
heat-labile nutrients [1,2]. Pathogens such as Klebsiella pneumoniae have been detected on surfaces
surrounding infected patients in healthcare settings with poor surface disinfection policies [3]. Despite
the importance of surface disinfection, the choice of biocidal products (disinfectant) and disinfection
frequency does not always depend on consequences for patients and staff if a pathogen remain
uncontrolled on surfaces [4–7]. The use of disinfectants for general purposes is subject to controversies,
despite the importance of surface disinfection being recognized [8–13]. One of the main concerns
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associated with the use of disinfectants is the development of biocide tolerance and/or cross-resistance
to other biocides or even chemotherapeutic antibiotics as a consequence of the selective pressure exerted
towards bacteria, especially when a biocidal product is misused [14,15]. Indeed, decreased bacterial
susceptibility following exposure to suboptimal biocide concentrations, the use of an inappropriate
biocide, or not following manufacturers’ guidelines, resulting in inappropriate product usage, has been
documented [16–18].
There is scope for the development of new biocidal formulations with potent activity and
decreased toxicity. The use of appropriate excipients that can work synergistically with the main
biocide in order to increase the overall efficacy of a formulation provides an interesting avenue,
notably to combat the rise of antimicrobial resistance [19,20]. The use of phytochemicals in particular
offers a potential solution as an excipient [21]. This study focuses on cetyltrimethylammonium
bromide (CTAB) and cinnamaldehyde. Quaternary ammonium compounds (QACs), such as CTAB,
are among the most widely used biocides. CTAB is a cationic surfactant whose antibacterial activity is
concentration-dependent. The positively charged form of CTAB interacts with the negative-charged
bacterial membrane by nonselective electrostatic interactions. At low concentrations, it interferes
with bacterial growth, inducing the cellular leakage of potassium and hydrogen ions, as well as loss
of the ability for osmoregulation [22–24]. At higher concentrations, bacteria are killed due to the
solubilization of the cellular membrane that ultimately leads to a fast leakage of cell components [22,23].
In addition, CTAB can generate superoxide and hydrogen peroxide and inhibit the regulatory gene
sosS function and decrease manganese superoxide dismutase activity, leading to cell death [25].
Cinnamaldehyde occurs naturally in plants of the genus Cinnamon and is already known for
its antimicrobial properties [26–28]. Cinnamaldehyde is already approved by the Food and Drug
Administration of the United States and has the Generally Recognized as Safe status by the Flavor and
Extracts Manufactures’ Association of the USA [29]. It can be used in air care products, perfumes and
fragrances, polishes and waxes, washing and cleaning products, cosmetics and personal care products,
and pharmaceuticals and biocides in the European Union [30].
The main goal of this work is to explore the possibility of a CTAB-cinnamaldehyde combination
for the development of a formulation to be used with wipes for surface disinfection. To achieve this aim,
the study was initiated using Staphylococcus aureus as a reference microorganism and Escherichia coli to
corroborate the results achieved. The suspension test was used for formulation adjustments, and the
evaluation of the efficacy of the final formulation was assessed through surface wiping.
2. Results
2.1. Formulation Optimization—Without Soil Load
The efficacy of formulations combining QAC and a phytochemical were tested using the
standardized efficacy test EN 1276:2009 [31]. A CTAB concentration of 0.04 mM, which allows
a reduction in S. aureus of circa 5 log10 colony-forming units (CFU) mL−1, was selected to assess the
impact of the phytochemical on the efficacy of the combination. CTAB was combined with different
concentrations (0.5 mM, 1 mM, and 2 mM) of cinnamaldehyde. The CFU reduction obtained by the different
concentrations of cinnamaldehyde alone was almost negligible (0.5 mM: 0.08 ± 0.04 log10 CFU mL−1,
1 mM: 0.07 ± 0.08 log10 CFU mL−1, and 2 mM: 0.05 ± 0.00 log10 CFU mL−1). After five-min contact,
the combination CTAB-cinnamaldehyde showed a higher efficacy in comparison to CTAB alone.
The best efficacy was achieved with 0.04-mM CTAB combined with 1-mM cinnamaldehyde (p > 0.05),
resulting in a bacterial reduction of 5.97 ± 0.33 log10 CFU mL−1 (Figure 1).
The concentration of CTAB was reduced in half to better measure the impact of cinnamaldehyde
when in combination, since a reduction of 4.25 ± 0.85 log10 CFU mL−1 was reached when CTAB
was used alone (Figure 1). Two solvents, dimethyl sulfoxide (DMSO) and isopropanol were used
to solubilize the phytochemical (maximum concentration of 5% v v−1). The combination of CTAB
(0.02 mM)-cinnamaldehyde had a higher efficiency in comparison to CTAB alone, regardless the solvent
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used (Figure 2). The combination caused a reduction of 1.99 ± 0.48 and 4.00 ± 0.76 log10 CFU mL−1
whether cinnamaldehyde was dissolved in DMSO or isopropanol (p < 0.001), respectively. CTAB alone
promoted a reduction of 1.31 ± 0.18 and 1.73 ± 0.33 log10 CFU mL−1 when in the presence of 5% v v−1
of DMSO or isopropanol, respectively (Figure 2). Exposure of a S. aureus bacterial suspension for five
min to 1 mM of cinnamaldehyde alone was reduced 0.05 ± 0.02 log10 CFU mL−1 if dissolved in DMSO
or 0.04 ± 0.05 log10 CFU mL−1 when isopropanol was used. The CFU reduction obtained with the
combination just by changing the solvent from DMSO to isopropanol was significantly higher (p < 0.01).
Therefore, the subsequent studies were carried out using isopropanol as the cinnamaldehyde solvent.
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Figure 1. Staphylococcus aureus colony-forming unit (CFU) reduction after exposing a bacterial
suspension for 5 min to 0.04-mM cetyltrimethylammonium bromide (CTAB) (black) alone or in
combination (grey) with different concentrations of cinnamaldehyde. Values are mean ± SD. No statistical
significance was observed between CTAB alone and any of the combinations (p > 0.05).
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Figure 2. S. aureus reduction after exposing a bacterial suspension for 5 min to 0.02-mM CTAB (black)
alone or in combinati with 1 mM of cinnamaldehyde (grey) when two different solvents were used
on the formulati (dimethyl sulfoxide (DMSO) or isopropanol). Values are mean ± SD. Th statistical
significance is represented (** p < 0.01 and *** p < 0.001).
The combination CTAB-cinnamaldehyde was also tested at pH 7 and 8 against S. aureus and E. coli
(Figure 3). Exposing bacterial suspensions to 1 mM of cinnamaldehyde alone led to a reduction of
0.04 ± 0.05 log10 CFU mL−1 in S. aureus and 0.05 ± 0.06 log10 CFU mL−1 in E. coli at pH 7. At pH 8,
a reduction of 0.02 ± 0.10 log10 CFU mL−1 in S. aureus and 0.06 ± 0.07 log10 CFU mL−1 in E. coli was
observed. When the combination of CTAB and the phytochemical was assessed against S. aureus
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(Figure 3), the pH impacted the efficiency of CTAB alone. In this case, a reduction of 1.73 ± 0.33 log10
CFU mL−1 was achieved at pH 7, while a reduction of 3.89 ± 0.60 log10 CFU mL−1 (p < 0.001) was
obtained for pH 8. However, when CTAB was combined with cinnamaldehyde, the S. aureus reduction
at pH 7 was 4.00 ± 0.76 log10 CFU mL−1, while, at pH 8, was 3.90 ± 0.89 log10 CFU mL−1. Considering
E. coli (Figure 3), it was possible to observe that the effect of CTAB alone was higher at pH 8 (p > 0.05).
In addition, only at pH 7, it was observed a positive effect of the presence of 1 mM of cinnamaldehyde
on E. coli reduction, from a 2.29 ± 0.40 log10 CFU mL−1 reduction of CTAB alone to a 2.69 ± 0.87 log10
CFU mL−1 reduction when combined with cinnamaldehyde (p > 0.05). A pH of 7 was selected for
the formulation.
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Figure 3. S. aureus and Escherichia coli CFU reduction after exposing a bacterial suspension for 5 min
to 0.02-mM CTAB alone (black columns) or in combination with 1 mM of cinnamaldehyde (grey
columns) when two different pH, pH 7 or pH 8, were used i the formulation. Values are mean ± SD.
The statistical significance is resented (** p < 0.01 and *** p < 0.001).
2.2. Formulation Optimization—Improving Activity against Gram-Negative Bacteria
To improve the efficacy of the formulation against the Gram-negative bacterium,
ethylenediaminetetraacetic acid (EDTA) was added to the formulation. EDTA is an ion chelator
that interacts with Ca2+-destabilizing lipopolysaccharides in the Gram-negative outer membrane,
which results in increased permeability [32,33]. Accordingly, the screening of different concentrations
of cinnamaldehyde, EDTA, and CTAB were performed (data not shown). A combination of 1-mM
cinnamaldehyde, 25-mM EDTA, and 0.5-mM CTAB was chosen for further testing and optimization
(Table 1).
Table 1. Concentrations tested for cinnamaldehyde, EDTA, and CTAB in combination by using the
suspension test against Escherichia coli NCTC 10418. EDTA: ethylenediaminetetraacetic acid and CTAB:
cetyltrimethylammonium bromide.
Cinnamaldehyde (mM) EDTA (mM) CTAB (mM)
1 10 0.02
25 0.02 < (CTAB) < 0.5
0.5
0.5 < (CTAB) < 1
1
2.3. Formulation Optimization—With Soil Load
A biocidal product needs to be active with and without the presence of soil load. To understand
the performance of the formulation, both under clean (0.3 g L−1) and dirty conditions (3 g L−1),
S. aureus and E. coli were exposed to CTAB, CTAB-cinnamaldehyde, and CTAB-cinnamaldehyde-EDTA
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(Figure 4). The efficacy of the formulation (CTAB-cinnamaldehyde-EDTA) against S. aureus was
confirmed, as a total CFU reduction for clean and dirty conditions was observed, 5.78 log10 CFU mL−1
(Figure 4). The combination of CTAB-cinnamaldehyde was used under clean and dirty conditions,
and a higher concentration of interfering substance decreased its efficacy against S. aureus, from
5.78 ± 0.00 to 3.20 ± 0.00 log10 CFU mL−1 (p < 0.001). When in contact with E. coli, the best results were
obtained under clean conditions. The highest efficacy achieved for E. coli was observed for CTAB alone
and CTAB-cinnamaldehyde-EDTA, with reductions of 3.50 ± 1.29 log10 CFU mL−1 and 3.27 ± 0.54
log10 CFU mL−1, respectively. When the bacterial suspension concentration was reduced to one-third
(Figure 4), CTAB-cinnamaldehyde-EDTA showed a higher reduction of 4.69 ± 0.64 log10 CFU mL−1
and 4.20 ± 0.89 log10 CFU mL−1 under clean and dirty conditions, respectively (p > 0.05). At this point,
it was decided to use the following formulation for the subsequent studies: 1-mM cinnamaldehyde,
25-mM EDTA, 0.5 mM CTAB in phosphate buffer (PB) at pH 7, and with 5% v v−1 isopropanol.
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Figure 4. Bacterial reduction following exposure to formulations in the presence of soil load. (a). S. aureus
(filled columns) and E. coli (pattern columns) CFU reductions after exposing a bacterial suspension
for 5 min to CTAB alone, CTAB in combination with cinnamaldehyde, or CTAB in combination with
cinnamaldehyde and ethylenediaminetetraacetic acid (EDTA). The test was performed under clean
(black columns) or dirty (grey columns) conditions. (b). E. coli CFU reduction after exposing a
3-times less-concentrate bacterial suspension for 5 min to CTAB lone, CTAB in combination with
cinnamaldehyde, or CTAB in combination with cinnamaldehyde and EDTA. The test was performed
under clean (0.3 g L−1; grey columns) or dirty (3 g L−1; black columns) conditions. The horizontal
dashed line in the figure represents a total reduction of bacteria considering the method limit of
detection ((a) represented only for S. aureus 5.78 log10 CFU mL−1 and (b) 5.30 log10 CFU mL−1 for
E. coli). Values are mean ± SD. The statistical significance is presented (*** p < 0.001).
2.4. Surface Wiping—Mechanical and Formulation Efficacy
As this formulation was to be used in combination with wipes, it is important to measure the
efficacy of the product (formulation-wipe) rather than just the formulation alone [34]. To deliver
the formulation, two different types of wipe materials were chosen (wipe A and B; Supplementary
Materials A.3.). With the surface-wiping method, it was possible to study the ability to remove and
kill bacteria from a contaminated surface (D1) and bacterial transfer to clean surfaces (D1.1 and D1.2).
On their own, both wipe materials had the same effect (p > 0.05) on S. aureus removal from surfaces
(Figure 5). In the contaminated surface D1, after wiping with wipe A, 5.38 ± 0.20 log10 CFU remained
in the disc and, with wipe B, 5.19 ± 0.33 log10 CFU. While, in D1.1, 4.91 ± 0.52 log10 CFU and 4.88 ± 0.40
log10 CFU remained on the surface, in D1.2, 4.65 ± 0.47 log10 CFU and 4.68 ± 0.36 log10 CFU remained
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after using wipe A or B, respectively. When the wipes were impregnated with the formulation,
a significant reduction (p < 0.001) of S. aureus on the surfaces was observed; only 2.76 ± 0.22 log10
CFU (wipe A) and 3.64 ± 0.24 log10 CFU (wipe B) remained on the surface, while the number of
CFU on D1.1 and D1.2 were below the detection limit regardless of the wipe used. E. coli removal
from surfaces (without formulation) was similar (p > 0.05) for both wipes (Figure 5). In fact, when
wipe A was used, 3.42 ± 0.46 log10 CFU remained on the surface and, with wipe B, 3.73 ± 0.53 log10
CFU. As with S. aureus, the wipes on their own were not very effective (<log reduction) in reducing
the number of E. coli on surfaces. In fact, when wipe A was used, D1.1 showed a contamination of
3.18 ± 0.35 log10 CFU and D1.2 of 2.80 ± 0.62 log10 CFU and, with wipe B, D1.1 a contamination of
3.61 ± 0.38 log10 CFU and D1.2 of 3.52 ± 0.74 log10 CFU. When the wipes were impregnated with the
formulation, a significant decrease in E. coli concentration on the surfaces was observed (Figure 5).
In fact, for wipe A, the CFU were below the detection limit, 1.49 log10 CFU, on D1 (p < 0.001), D1.1
(p < 0.01), and D1.2 (p < 0.05) when compared to the wipe without formulation. When wipe B was
impregnated with the formulation, a 2.05 ± 0.79 log10 CFU remained on D1 (p < 0.01), and the CFU
were below the limit of detection on D1.1 (p < 0.01) and on D1.2 (p < 0.01) in comparison to the wipe
without the formulation.
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Figure 5. Remaining CFU on the contaminated surface (D1) and on two clean surfaces (D1.1 and
D1.2) after being wiped with wipe A or B. S. aureus and E. coli were used as surfaces contaminants.
Mechanical (filled columns) and biocidal (columns with pattern) actions were evaluated. Values are
mean ± SD. Horizontal dashed line represents the limit of detection of the method (1.49 log10 CFU).
The statistical significance is represented (* p < 0.05, ** p < 0.01, and *** p < 0.001).
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A summary of the effectiveness of wipe A and B on the overall cell removal (bacteria that were
removed and killed during the process of wiping three surfaces) is shown in Figure 6. In total, wipe A
mechanical action removed from the surface 1.50 ± 0.35 log10 CFU of S. aureus and 2.45 ± 0.41 log10
CFU of E. coli, while wipe B removed 1.66 ± 0.31 log10 CFU of S. aureus and 2.06 ± 0.41 log10 CFU
of E. coli. The efficacy of the wipe was improved when impregnated with the formulation. In fact,
the impregnated wipe A was able to remove 4.27 ± 0.22 log10 CFU of S. aureus (p < 0.001) and 4.35 ± 0.22
log10 CFU of E. coli (p < 0.001), while wipe B removed 3.47 ± 0.23 log10 CFU of S. aureus (p < 0.001) and
4.04 ± 0.46 log10 CFU of E. coli (p < 0.001).
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2.5. Formulation Chemical Stability
A p eliminary study was performed to check for the potential chemical interaction of the
phytochemical with the biocide or other components of the formulation. From the analysis of the
1H NMR spectra (Figure 7), it was possible to conclude that cinnamaldehyde maintains its chemical
integrity as part of a mixture with CTAB-EDTA, whether in water or as a formulation. The same type
of signals was observed in the comparative analysis with the spectrum of cinnamaldehyde.
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3. Discussion
Inefficient cleaning and disinfection will contribute to surface contamination and microbial
spreading, which, overall, may impact on the infection rate [8,35]. There are many protocols to impart
cleaning or disinfectant formulations on surfaces, but the majority use some form of wiping [34,36].
To ensure microbicidal efficacy, a biocidal product needs to be tested in accordance with official
standards, such as the EN 1276:2009 “Chemical disinfectants and antiseptics” in Europe [31]. According
to this particular standard test, a reduction of 5 log10 CFU mL−1 must be achieved. In this work,
we explored a formulation combining both CTAB and cinnamaldehyde, which was found to be
synergistic in our previous work [21,37,38]. Initially, the combination of CTAB (0.04 mM) with 1 mM of
cinnamaldehyde was found to be an efficient bactericidal, killing more than 5 log10 CFU mL−1 within
a five-min contact time (Figure 1). CTAB is a cationic surfactant whose mode of action is related to
the denaturation of proteins, inducing changes in the properties of the cell membrane and facilitating
the entrance of other antimicrobials into the bacterial cell [24]. This cationic surfactant is also able
to concentrate, solubilize, and compartmentalize ions and molecules, a process that can enhance its
antimicrobial action and, also, of other antimicrobials [39]. In this work, it was hypothesized that the
combined effect of CTAB with cinnamaldehyde may be advantageous, as this phytochemical has a
low MW (132.162 g mol−1) and lipophilicity, which are parameters that can facilitate cinnamaldehyde
permeation across the bacterial membrane [27,40]. Cinnamaldehyde is described to be able to react with
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membranes, proteins, nucleic acids, lipids, and carbohydrates of E. coli [41]. It was also hypothesized
that low concentrations of cinnamaldehyde can act on the cell membrane components, and, at a higher
dosage, it can diffuse into the bacteria, modifying the cytoplasm enzymes in the transcriptome
and, consequently, promoting cell death [40,42–44]. At a reduced concentration of 0.2-mM CTAB,
the formulation did not perform as well against Gram-negative compared to Gram-positive. The use
of isopropanol as a solvent and a chelator (EDTA) improved the efficacy of the formulation (Figures 2
and 4). The difference in antimicrobial susceptibility between Gram-negative and Gram-positive
bacteria has been well-reported [33,45,46]. The chelator EDTA was used to increase the efficacy of the
formulation in Gram-negative bacteria, as it disrupts the lipopolysaccharide structure in the outer
membrane of Gram-negative bacteria [16,46]. Some authors hypothesized that the presence of EDTA
can cause potentiation as a result of a loss of barrier function of the outer membrane, such as efflux
pumps inhibition, as well as an enhanced uptake mechanism or removal of inactivating factors that are
found in the membrane or in the periplasmic space [32,46,47]. The use of EDTA has been reported as a
potentiator of the activity of antimicrobials, antibiotics, preservatives, and cationic surfactants such as
QACs [32,33,47,48]. In fact, when combined with a QAC, EDTA even demonstrated synergy against
Pseudomonas aeruginosa, and an inhibition model of the EDTA mode of action was suggested [46].
One happens below a threshold concentration and, according to the literature, is a general inhibitory
process, such as removing metal ions from the growth medium, while the second, that happens at a
higher concentration, corresponds to the destabilization of the outer membrane that, consequently,
leads to cell lysis.
The presence of an organic load can impact negatively the efficacy of a formulation [16,17],
and indeed, the activity of the formulation developed (1-mM cinnamaldehyde, 25-mM EDTA,
and 0.5-mM CTAB in PB pH 7 with 5% v v−1 isopropanol) was reduced (Figure 4). Wipes, cloths,
etc. are usually used in combination with a formulation [34]. One advantage of prewetted wipes
is the additional mechanical effect contributing to the overall reduction of microorganisms from the
surface. The importance of testing a final product is reflected with the use of standard efficacy tests
such as the Wiperator test (ASTM E2967−15) or the efficacy evaluation of surface disinfection wipes test
(EN 16615-15) [49,50]. The combination of the formulation with wipe material improved the overall
efficacy of the product while preventing the transfer of bacteria to other surfaces (Figure 5). Measuring
the ability to prevent bacterial transfer together with a reduction in bacterial viability provides a better
understanding of the effectiveness of biocidal products to render a safe surface [51,52].
In this study, we showed that a promising synergistic effect between CTAB and cinnamaldehyde [32–34]
can be translated into a formulation that, when combined with a wipe material, can deliver bactericidal
efficacy on surfaces. This, in turn, opens up the prospect of using phytochemicals as excipient to
improve the effectiveness of a biocidal product.
4. Materials and Methods
4.1. Chemicals and Test Solutions
CTAB (CAS: 57-09-0), was purchased from Acros Organics (Portugal), while cinnamaldehyde
(CAS: 14371-10-9) and bovine serum albumin (BSA) were purchased from Sigma Aldrich (Portugal).
EDTA was acquired from Panreac. Lecithin, polysorbate 80, thiosulphate, saponin, isopropanol,
and DMSO were obtained from VWR Chemicals. L-histidine was purchased from Merck. All reagents
were of analytical grade. Solutions of CTAB, BSA, and EDTA were prepared in sterile deionized water
and cinnamaldehyde in DMSO or isopropanol. The biocide and phytochemical neutralization step
was performed using the universal neutralizer (lecithin 3 g L−1, polysorbate 80 30 g L−1, thiosulphate
5 g L−1, L-histidine 1 g L−1, and saponin 30 g L−1 in 1% phosphate buffer 0.25 M, pH 7.2) for 10 min,
which was shown to be efficient in inactivating the biocidal activity and to be nontoxic to the test
bacteria (data not shown).
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4.2. Microorganisms, Culture Conditions, and Test Solutions
Staphylococcus aureus NCTC 10788 and Escherichia coli NCTC 10418 were used in this study. Test
suspensions were obtained from overnight cultures in 100-mL flasks with 25 mL of Mueller-Hinton
broth prepared in phosphate buffer (0.02 M pH 7 and PB pH 7) incubated at 37 ◦C and under 150 rpm
agitation on an orbital shaker (25 mm of orbital radius, Agitorb 200ICP), as described previously [21,38].
4.3. Bactericidal Suspension Test
The suspension test used was adapted from the EN 1276:2009 [31]. Briefly, the overnight culture
was washed once with PB, pH 7, and the bacterial suspension was adjusted to an OD600 nm of 0.33
with PB, pH 7 (1.5–5 CFU mL−1). A volume of 900 µL of cell suspension was added to an Eppendorf
containing cinnamaldehyde (5% v v−1 of solvent and 0.5 mM, 1 mM, and 2 mM of cinnamaldehyde)
and CTAB (from 0.005 to 1 mM) for a total of 1 mL of test solution and vortexed for 5 s. Before adding
the bacterial cells, the test solution was incubated statically for 2 min at 25 ± 3 ◦C. Incubation at
25 ± 3 ◦C was allowed to occur for 5 min. A volume of 100 µL of the test solution was placed in 900 µL
of neutralizer for 10 min, and CFU determination was performed. CFU were determined after 24 h at
30 ◦C incubation and presented as log10 CFU cm−2. Three independent experiments were performed
for each condition tested.
To test the impact of the organic load, 500 µL of cell suspension (OD600 nm at 0.6) were added
to an Eppendorf containing a phytochemical/derivative (5% v v−1 of solvent and 1 mM or 2 mM of
cinnamaldehyde final concentration), CTAB (0.02 to 1 mM), EDTA (10 mM or 25 mM), BSA (0.3 g L−1
or 3 g L−1 for clean or dirty conditions), and 250 µL of PB, pH 7, for a total of 1 mL of test solution.
The results are presented as log10 CFU mL−1.
4.4. Surface Wiping Assay
A surface wiping assay protocol was developed for the accomplishment of this data (for more
information, see Supplementary Materials A.1., A.2., and A.3.).
4.4.1. Preparation of the Contaminated Surface D1
An overnight culture was washed twice with PB pH 7, and the cell suspension was adjusted
to 1.5–5 × 109 CFU mL−1 (Supplementary Materials A.1.) [49,50]. Prior to using the cell suspension,
0.5 mL of ten-times concentrated BSA (final concentration 0.3 g L−1) was added to 4.5 mL of bacterial
suspension and vortex for 30 s. A volume of 10 µL of this suspension was transferred to the center of a
clean and sterile stainless-steel disc (2-cm diameter) and allowed to completely dry at 37 ± 3 ◦C for
30 min (D1).
4.4.2. Preparation of the Wipe Carrier
The control solution (0.1% polysorbate 80 in water) and the formulation (1-mM cinnamaldehyde
dissolved in 5% v v−1 isopropanol, 0.5-mM CTAB, and 25-mM EDTA in 20-mM PB, pH 7) were freshly
prepared for each experiment. The wipe (4 × 4 cm2) was presoaked in 20 mL of solution, ensuring the
wipe was completely covered for 2 min at room temperature (25 ± 3 ◦C). With a clean pair of gloves,
the wipe was wrung to drain the excess of liquid and weighted after removal of the excess liquid:
wipe A—0.233 ± 0.030 g and 0.214 ± 0.031 g and wipe B—0.370 ± 0.019 g and 0.355 ± 0.017 g for the
control and formulation, respectively. The wipe was then wrapped onto the carrier and fixed with a
rubber band (Supplementary Materials A.2.).
4.4.3. Wiping Test
The wiping test was performed as presented in Figure 8. Briefly, D1 was placed on the holder
with two clean and sterile stainless-steel discs next to it. The wipe carrier was placed on the top of D1,
and with the help of forceps, the wipe carrier was moved (without putting any pressure on the wipe
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carrier) towards the disc for 1 min vertically and horizontally, as described in the diagram showed in
Figure 8. The wipe carrier was then moved to D1.1 and D1.2, repeating the surface wiping movement
for 1 min for each disc (Figure 8). After wiping of all three discs, each disc was placed in 5 mL of
universal neutralizer with 2 g of glass beads and vortexed for 5 s. Neutralization was allowed to occur
for 10 min. Discs were then vortexed for 30 s, and CFU determination was performed as described
before. The results are presented as a log10 CFU mL−1 reduction or log10 CFU.
Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 11 of 15 
 
4.4.2. Preparation of the Wipe Carrier  
The control solution (0.1% polysorbate 80 in water) and the formulation (1-mM cinnamaldehyde 
dissolved in 5% v v−1 isopropanol, 0.5-mM CTAB, and 25-mM EDTA in 20-mM PB, pH 7) were freshly 
prepared for each experiment. The wipe (4 × 4 cm2) was presoaked in 20 mL of solution, ensuring the 
wipe was completely covered for 2 min at room temperature (25 ± 3 °C). With a clean pair of gloves, 
the wipe was wrung to drain the excess of liquid and weighted after removal of the excess liquid: 
wipe A—0.233 ± 0.030 g and 0.214 ± 0.031 g and wipe B—0.370 ± 0.019 g and 0.355 ± 0.017 g for the 
control and formulation, respectively. The wipe was then wrapped onto the carrier and fixed with a 
rubber band (Supplementary Materials A.2.). 
4.4.3. Wiping Test 
The wiping test was performed as presented in Figure 8. Briefly, D1 was placed on the holder 
with two clean and sterile stainless-steel discs next to it. The wipe carrier was placed on the top of 
D1, and with the help of forceps, the wipe carrier was moved (without putting any pressure on the 
wipe carrier) towards the disc for 1 min vertically and horizontally, as described in the diagram 
showed in Figure 8. The wipe carrier was then moved to D1.1 and D1.2, repeating the surface wiping 
movement for 1 min for each disc (Figure 8). After wiping of all three discs, each disc was placed in 
5 mL of universal neutralizer with 2 g of glass beads and vortexed for 5 s. Neutralization was allowed 
to occur for 10 min. Discs were then vortexed for 30 s, and CFU determination was performed as 
described before. The results are presented as a log10 CFU mL−1 reduction or log10 CFU. 
 
Figure 8. Schematic representation of the wiping assay steps. 
4.5. Evaluation of Phytochemical/Biocide Chemical Interaction Study by Nuclear Magnetic Resonance 
Spectroscopy 
1H NMR (nuclear magnetic resonance) data were acquired on a Bruker Avance III 400 NMR 
spectrometer operating at 400.15 MHz. The relaxation delay was 90° pulse, a spectral width of 8012 
Hz, and 65 K data points. 1H NMR spectra of the samples were recorded at room temperature (25 ± 3 
°C) in 5-mm outer diameter tubes. The samples were prepared in deuterated water. TMSP-d4 (3-
(trimethylsilyl) propionic-2,2,3,3-d4 acid sodium salt) was used as the internal reference. 
Figure 8. Sche atic representation of the iping assay steps.
4.5. Evaluation of Phytochemical/Biocide Chemical Interaction Study by Nuclear Magnetic Resonance Spectroscopy
1H NMR (nuclear magnetic resonance) data were acquired on a Bruker Avance III 400 NMR
spectrometer operating at 400.15 MHz. The relaxation delay was 90◦ pulse, a spectral width of
8012 Hz, and 65 K data points. 1H NMR spectra of the samples were recorded at room temperature
(25 ± 3 ◦C) in 5-mm outer diameter tubes. The samples were prepared in deuterated water. TMSP-d4
(3-(trimethylsilyl) propionic-2,2,3,3-d4 acid sodium salt) was used as the internal reference.
4.6. Statistical Analysis
The statistical program GraphPad Prism version 6 was used to analyze the data. One-way
analysis of variance (one-way ANOVA) followed by the post hoc Dunnett’s multiple comparison test.
Confidence levels of ≥95% (p < 0.05), ≥99% (p < 0.01), and ≥99.9% (p < 0.001) were used to consider
statistical significance. The results were presented as the average and standard deviation (SD) of three
independent experiments for each sample.
5. Conclusions
In this study, we showed that a promising synergistic effect between CTAB and cinnamaldehyde
can be translated in a formulation that, when combined with a wipe material, can deliver bactericidal
efficacy on surfaces. This, in turn, opens up the prospect of using phytochemicals as excipients to
improve the effectiveness of a biocidal product.
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